Highlights of Contemporary Genetically Altered Models may be contributed or invited and is meant to acquaint toxicologic pathologists with important biological and morphological features of newly established transgenic, knock-out, and related genetically engineered animal models. Although these Highlights will be based upon previously published papers, submissions will be peer reviewed. Suggested format includes background; experimental approach; biological, clinical, and pathologic (lesions, pathogenesis, and histomorphology) features; applications and implications.
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BACKGROUND
The human major histocompatibility class (MHC) I allele HLA-B27 is closely associated with chronic inflammatory multisystem diseases collectively called spondyloarthropathies (3) . These include ankylosing spondylitis, a chronic inflammatory disease affecting the axial musculoskeletal system; juvenile spondylarthropathy; reactive arthritis, a disease of joints and other tissues that is triggered by microbial infection of the gastrointestinal or genitourinary tracts; and psoriatic arthropathy, a disease closely resembling psoriasis vulgaris. HLA-B27 is a serologically defined determinant of the HLA-B locus. The HLA gene product and its associated light chain, humañ 2-microglobulin (h~2m), form the MHC I complex on the cell surface of most nucleated cells (4) .
Attempts have been made to produce animal models of spontaneous and inherited human spondyloarthropathies but have not been successful. Transgenic mice for human HLA-B27 and h~2m have been produced, however, no faithful reproduction of any of the features of HLA-B27-associated human disease has been reported (6) .
Rats made transgenic for and expressing high copy numbers of the human HLA-B27 and h~2m gene products develop spontaneous inflammatory conditions in a number of organs and systems. These include spontaneously developed inflammatory diseases involving the gastrointestinal tract, peripheral and vertebral joints, male genital tract, skin, nails, and heart. These inflammatory conditions and organ locations bear striking resemblances to the inherited human HLA-B27-associated disorders. Not only does the HLA-B27 transgenic rat have pathologic similarities to human HLA-B27-associated diseases; the susceptibility to inflammatory disease in the transgenic rat correlates also with the level of HLA-B27 expression (7) . In addition, the HLA-B27-associated inflammatory diseases can be transferred from transgenic rats to irradiated disease-resistant and nontransgenic rats via bone marrow engraftment (2) . Furthermore, T cells, but not thymic exposure, are required for inflammatory disease of HLA-B27 transgenic rats (1) . HLA-B27 transgenic rats of the Fischer-344 strain also have a high prevalence of colorectal cancer in association with chronic inflammatory bowel disease, making this a model of spontaneous colorectal neoplasia not associated with germline modifications of known cancer-related genes (5) .
EXPERIMENTAL APPROACH
In generating HLA-B27 and h(32m rats, fertilized 1-cell rat eggs were microinjected with a solution containing both DNA fragments (at 1.5 ng/~,1) for HLA-B27 and h~32m. The HLA-B27 gene encoded the HLA-B2705 subtype contained on a 6.5-kb fragment with 0.7-kb 5' and 2.5-kb 3' flanking sequences. To determine the HLA-B27 and h(32m genotype of the offspring, dot-blot hybridization of digested genomic DNA isolates from rat pup tail tip was analyzed. Hybridizing probes to genomic DNA consisted of a 5' and 3' flanking probe for the HLA-B locus and probe fragments containing exons 2 and 3 of h~32m. In addition, RNA analysis by Northern blot hybridization was carried out on total cellular RNA extracted from tissues. HLA-B27 and h(32m messenger RNA was detected using 3' probes for untranslated messenger RNA.
BACKGROUND STRAINS
Egg donors were immature female Lewis or Fischer-344 rats. The rats were superovulated by continuous infusion of follicle-stimulating hormone and mated with fertile males. One day following breeding, fertilized 1-cell eggs were harvested from the oviducts of bred females.
Eggs were microinjected with HLA-B27 and hf32m DNA and transferred to day 1 pseudopregnant Sprague-Dawley females. The offspring were analyzed for transgene expression, and founder animals were crossed to homozygosity. Homozygous HLA-B27 and h~3~m transgenic rats were screened for gene copy expression and characterized by copy number as either high or low expression. in the gastrointestinal tract, peripheral and axial joints (4), skin and nails (8) , testes and epididymis, and heart (4). HLA-B27/h¡32m transgenic rats expressing low copy numbers of the transgenes and nontransgenic controls were found to have no clinical or histological disease.
The clinical and pathological changes observed for the gastrointestinal tract consisted of persistent diarrhea clinically manifested as frequent voluminous and watery stools and histologically as a chronic lymphoplasmocytic gastritis, enteritis, and colitis. The inflammation was primarily restricted to the lamina propria but occasionally extended to the submucosa. In addition, hyperplasia of the mucous neck cells of the stomach and crypt epithelium accompanied the inflammatory changes. No etiologic agent or cause was found to be associated with the gastrointestinal lesions. HLA-B27/h¡32m transgenic rats expressing low copy numbers of the genes and nontransgenic cagemates housed with affected animals did not show signs of disease.
The clinical disease in the peripheral and axial joints consisted of swelling and tenderness of the tarsal and carpal joints of one or both hindlimbs or forelimbs, respectively. The arthritic clinical disease in some affected animals undulated with patterns of remission and exacerbation. Histologically, the lesions in the affected joints consisted of large accumulations of neutrophils in the joint space, proliferation of the synovium with edema and infiltration of lymphocytes, plasma cells and neutrophils, and destruction of articular cartilage and pannus formation. In severe cases of pannus, fibrous ankylosis occurred. In some cases, inflammation extended from the joint capsule to the adjacent tendons and ligaments. Inflammatory arthritic changes were also noted in vertebral joints of the tail in a small number of animals examined.
Clinical and histological changes in the skin and nails consisted of psoriasiform lesions of the tail and dystrophy of the digits with histologically marked orthokeratotic hyperkeratosis and parakeratosis, exocytosis of lymphocytes, and neutrophils and spongiform foci in the epidermis. In addition, a progressive alopecia of the head, face, trunk, and extremities with perifollicular and follicular mononuclear cell infiltrates is seen in affected transgenic animals.
In male transgenic rats, an orchitis manifested by progressive enlargement of the testes, followed by atrophy, was clinically noted. Histologically, the testicular tunica was thickened by connective tissue accompanied by a lymphoplasmocytic inflammatory cell infiltrate. In the testicular and epididymal tissues, there were numerous In a minority of hearts examined, multifocal inflammatory infiltrates were observed in the septum and ventricular walls. The infiltrates consisted of lymphocytes, plasma cell, macrophages, and eosinophils with myodegeneration and necrosis. In more chronic cases, fibrosis was also noted.
RELEVANCE TO HUMAN DISEASE
The HLA-B27/h~32m transgenic rat provides a unique animal model of human spondyloarthropathies. This model develops the entire spectrum of lesions associated with the human HLA-B27 allele-inherited spondyloarthropathies and is the first rodent model to develop lesions similar to those in humans. The model provides key information pertaining to the expression of the HLA-B27 and h(32m genes. This model is now being used to study the pathogenesis of HLA-B27-associated lesions, as well as the influence of microbial and the environment of the gastrointestinal and genitourinary tracts, immunological aspects of the disease and models for gene therapy and therapeutic drug development and efficacy.
